Update on Clinical Trials with Novel CETP Inhibitors to Raise HDL: Where Are We Today? - H. Bryan Brewer Jr., MD

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Update on Clinical Trials with Novel CETP Inhibitors to Raise HDL: Where Are We Today? presented by H. Bryan Brewer Jr., MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physiology technicians
  • Nurses and other allied healthcare professionals 
  • Imaging Specialists
  • Radiologists

Session Name: Atherosclerosis & Lipid Management

Track: Atherosclerosis & Research

Learning Objectives

  • The latest updates in Atherosclerosis & Research
Loading Simple Education